SCIENCE & TECHNOLOGY
News: Verdict on multiple sclerosis drug, a boost for Natco, Mylan.
Source: The Hindu
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system).
In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.
Signs and symptoms of MS vary widely and depend on the amount of nerve damage and which nerves are affected. Some people with severe MS may lose the ability to walk independently or at all, while others may experience long periods of remission without any new symptoms.
There's no cure for multiple sclerosis. However, treatments can help speed recovery from attacks, modify the course of the disease and manage symptoms.
Market Stabilization Scheme (MSS)
News: RBI to buy $120 bnGSecs under OMO.
Source: The Hindu
This scheme came into existence following a MoU between the Reserve Bank of India (RBI) and the Government of India (GoI) with the primary aim of aiding the sterilization operations of the RBI.
Historically, the RBI had been sterilizing the effects of significant capital inflows on domestic liquidity by offloading parts of the stock of Government Securities held by it. It is pertinent to recall, in this context, that the assets side of the RBI’s Balance Sheet (July 1 to June 30) includes Foreign Exchange Reserves and Government Securities while liabilities are primarily in the form of High Powered Money (consisting of Currency with the public and Reserves held in the RBI by the Banking System).
Thus, any rise in Foreign Exchange Reserves resulting from the intervention of the RBI in the Foreign Exchange Markets (with the intention, say, to maintain the exchange rate on the face of huge capital inflows) entails a corresponding rise in High Powered Money.
The Money Supply in the economy is linked to High Powered Money via the money multiplier. Therefore, on the face of large capital inflows, to keep the liabilities side constant so as to not raise the Supply of Money, corresponding reduction in the stock of Government Securities by the RBI is necessary.
The MSS was devised since continuous resort to sterilization by the RBI depleted its limited stock of Government Securities and impaired the scope for similar interventions in the future.
Under this scheme, the GoI borrows from the RBI (such borrowing being additional to its normal borrowing requirements) and issues Treasury-Bills/Dated Securities that are utilized for absorbing excess liquidity from the market. Therefore, the MSS constitutes an arrangement aiding in liquidity absorption, in keeping with the overall monetary policy stance of the RBI, alongside tools like the Liquidity Adjustment Facility (LAF) and Open Market Operations (OMO).
The securities issued under MSS, termed as Market Stabilization Scheme (MSS) Securities/Bonds, are issued by way of auctions conducted by the RBI and are done according to a specified ceiling mutually agreed upon by the GoI and the RBI. They possess all the attributes of existing Treasury-Bills/Dated Securities and are included as a part of the country’s ‘internal Central Government debt’.
The amount raised under the MSS does not get credited to the Government Account but is maintained in a separate cash account with the RBI and are used only for the purpose of redemption/buy back of Treasury-Bills/Dated Securities issued under the scheme.
However, following the global financial crisis of 2008, that necessitated fiscal stimulus measures, an amendment to the original MoU between the RBI and the GoI in February 2009 allowed the Government to convert a portion of the MSS funds into normal government borrowing for financing its stimulus expenditure requirements.
Treasury-Bills/Securities issued under MSS are matched by equivalent cash balances that are held by the Government with the RBI. Such payments are not made from the MSS account just as receipts due to premium or accrued interest on these Securities are not credited to it.